ONLINE DATABASE SEARCH - HIV-LS-289-MEMO
1. 42773 HIV-LS-289; PUBMED-HIV-2/11/2004
Purification of a novel low-molecular-mass laccase with HIV-1 reverse transcriptase inhibitory activity from the mushroom Tricholoma giganteum
Wang, HX and Ng, TB
Biochem Biophys Res Commun 2004. 315(2): 450-4
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14766229&dopt=abstract
2. 42774 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Chemokine receptor antagonists as HIV entry inhibitors
Anon
Expert Opinion on Therapeutic Patents 2004. 14(2): 251-255
3. 42775 HIV-LS-289; PUBMED-HIV-2/11/2004
Computer-Aided Design, Synthesis, and Anti-HIV-1 Activity in Vitro of 2-Alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin- 4(3H)- ones as Novel Potent Non-Nucleoside Reverse Transcriptase Inhibitors, Also Active Against the Y181C Variant
Ragno, R, Mai, A, Sbardella, G, Artico, M, Massa, S, Musiu, C, Mura, M, Marturana, F, Cadeddu, A, and La, Colla P
J Med Chem 2004. 47(4): 928-934
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14761194&dopt=abstract
4. 42776 HIV-LS-289; PUBMED-HIV-2/11/2004
Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals
Joshi, PJ, Fisher, TS, and Prasad, VR
Curr Drug Targets Infect Disord 2003. 3(4): 383-400
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14754437&dopt=abstract
5. 42777 HIV-LS-289; PUBMED-HIV-2/11/2004
Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design
Velazquez-Campoy, A, Muzammil, S, Ohtaka, H, Schon, A, Vega, S, and Freire, E
Curr Drug Targets Infect Disord 2003. 3(4): 311-28
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14754432&dopt=abstract
6. 42778 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Preparation of 5-substituted 1,2,4-triazole-3-carboxylic acid esters as intermediates for HIV integrase inhibitors via acylamidrazones((Shionogi and Co., Ltd. Japan)
Nagai, Masahiko, Noguchi, Koichi, and Uenaka, Masaaki
PATENT: JP 2004018480 A2; ISSUE DATE: 20040122
APPLICATION: 2002-46750; PP: 30 pp.
7. 42779 HIV-LS-289; PUBMED-HIV-2/11/2004
A review of HIV-1 resistance to the nucleoside and nucleotide inhibitors
Shulman, N and Winters, M
Curr Drug Targets Infect Disord 2003. 3(4): 273-81
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14754429&dopt=abstract
8. 42780 HIV-LS-289; PUBMED-HIV-2/11/2004
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents
Rao, A, Balzarini, J, Carbone, A, Chimirri, A, De Clercq, E, Monforte, AM, Monforte, P, Pannecouque, C, and Zappala, M
Farmaco 2004. 59(1): 33-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14751314&dopt=abstract
9. 42781 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives
Yoakim, C, Bonneau, PR, Deziel, R, Doyon, L, Duan, J, Guse, I, Landry, S, Malenfant, E, Naud, J, Ogilvie, WW, O'Meara, JA, Plante, R, Simoneau, B, Thavonekham, B, Bos, M, and Cordingley, MG
Bioorganic & Medicinal Chemistry Letters 2004. 14(3): 739-742
10. 42782 HIV-LS-289; PUBMED-HIV-2/11/2004
Anti-HIV-1 Protostane Triterpenes and Digeranylbenzophenone from Trunk Bark and Stems of Garcinia speciosa
Rukachaisirikul, V, Pailee, P, Hiranrat, A, Tuchinda, P, Yoosook, C, Kasisit, J, Taylor, WC, and Reutrakul, V
Planta Med 2003. 69(12): 1141-6
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14750032&dopt=abstract
11. 42783 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Use of chloroquine, hydroxychloroquine, and 4 aminoquinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards HIV sensitive strains and towards HIV strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors((Valpharma S. A., San Marino)
Valducci, Roberto, Alighieri, Tiziano, and Avanessian, Serozh
PATENT: EP 1374867 A1; ISSUE DATE: 20040102
APPLICATION: 2003-13823; PP: 17 pp.
12. 42784 HIV-LS-289; PUBMED-HIV-2/11/2004
Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity
Gaucher, B, Rouquayrol, M, Roche, D, Greiner, J, Aubertin, AM, and Vierling, P
Org Biomol Chem 2004. 2(3): 345-57
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14747863&dopt=abstract
13. 42785 HIV-LS-289; PUBMED-HIV-2/11/2004
Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G
Liu, B, Yu, X, Luo, K, Yu, Y, and Yu, XF
J Virol 2004. 78(4): 2072-81
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14747572&dopt=abstract
14. 42786 HIV-LS-289; PUBMED-HIV-2/11/2004
New anti-HIV protease inhibitors provide more treatment options
Nadler, J
AIDS Patient Care STDS 2003. 17(11): 551-64
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14746663&dopt=abstract
15. 42787 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Preparation of steroid-containing macrolide glycopeptides as carriers for steroid/non-steroid anti-inflammatory, antineoplastic, and antiviral active molecules ((Pliva D.D., Croatia)
Mercep, Mladen, Mesic, Milan, Tomaskovic, Linda, and Markovic, Stribor
PATENT: WO 2004005313 A2; ISSUE DATE: 20040115
APPLICATION: 2003; PP: 96 pp.
16. 42788 HIV-LS-289; SCIFINDER-HIV-2/4/2004
APOBEC-mediated DNA deamination as a mechanism of innate immunity to retroviral infection ((UK))
Malim, Michael H, Sheehy, Ann M, Harris, Reuben S, Bishop, Kate N, Neuberger, Michael S, Gaddis, Nathan C, and Simon, James HM
PATENT: US 20040009951 A1; ISSUE DATE: 20040115
APPLICATION: 46; PP: 35 pp., which
17. 42789 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Vaccines comprising inactivated HIV-pulsed antigen presenting cells and HIV protease inhibitor for treatment of AIDS((Fr.))
Andrieu, Jean-Marie and Lu, Louis
PATENT: US 20040009194 A1; ISSUE DATE: 20040115
APPLICATION: 2003-10537; PP: 29 pp.
18. 42790 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Method for the treatment or prevention of virus infection using polybiguanide-based compounds ((USA))
Labib, Mohamed E and Stockel, Richard F
PATENT: US 20040009144 A1; ISSUE DATE: 20040115
APPLICATION: 2003-42540; PP: 30 pp.
19. 42791 HIV-LS-289; PUBMED-HIV-2/11/2004
In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas
Shah, K, Tung, CH, Chang, CH, Slootweg, E, O'Loughlin, T, Breakefield, XO, and Weissleder, R
Cancer Res 2004. 64(1): 273-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14729634&dopt=abstract
20. 42792 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Preparation of acyclic nucleosides and nucleotides as antiviral agents((Taiwan))
Hakimelahi, Gholam Hossein
PATENT: US 2004002475 A1; ISSUE DATE: 20040101
APPLICATION: 2002-52806; PP: 21 pp.
21. 42793 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Inhibition of virus anchorage by RGG domain of a human cell surface-expressed protein, nucleolin, and uses for antiviral therapy((Fr.))
Hovanessian, Ara V and Briand, Jean-paul
PATENT: US 2004002457 A1; ISSUE DATE: 20040101
APPLICATION: 2003-56889; PP: 48 pp., which
22. 42794 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Preparation of ring-expanded nucleosides and nucleotides as virucides and bactericides((Nabi, USA and University of Maryland Baltimore County))
Hosmane, Ramachandra S and Sood, Ramesh K
PATENT: US 6677310 B1; ISSUE DATE: 20040113
APPLICATION: 99-33159; PP: 51 pp.
23. 42795 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Determining the replication capacity of viruses resistant to non-nucleoside inhibitors of reverse transcriptase in selection of drug therapy((Virologic, Inc. USA)
Huang, W, Wrin, Mary T, Gamarnik, Andrea, Beauchaine, J, Whitcomb, JM, Petropoulos, Christos J, and Parkin, Neil T
PATENT: WO 2004003513 A2; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 54 pp.
24. 42796 HIV-LS-289; SCIFINDER-HIV-2/4/2004
New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance ((Tibotec Pharmaceuticals, Ltd. Ire.)
Azijn, Hilde, De Bethune, Marie-Pierre, and Vingerhoets, Johan Hendrika Jozef
PATENT: WO 2004003227 A1; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 18 pp.
25. 42797 HIV-LS-289; SCIFINDER-HIV-2/4/2004
Preparation of 2,4-disubstituted pyridine N-oxides useful as HIV reverse transcriptase inhibitors ((Bristol-Myers Squibb Company, USA)
Rodgers, James D and Wang, Haisheng
PATENT: WO 2004002410 A2; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 71 pp.
26. 42798 HIV-LS-289; WOS-HIV-2/1/2004
Discovery of a Tat HIV-1 inhibitor through computer-aided drug design
Esquieu, D, Peloponese, JM, Opi, S, Gregoire, C, De Mareuil, J, Watkins, J, Campbell, G, Dunot, JP, Sturgis, J, Witvrouw, M, Pannecouque, C, De Clercq, E, Montembault, M, Giang, VT, Villieras, M, Fargeas, V, Lebreton, J, and Loret, EP
SPECTROSC-INT J 2003. 17(4): 639-645
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188061500001
27. 42799 HIV-LS-289; WOS-HIV-2/1/2004
Monoamine oxidase inhibition and CNS immunodeficiency infection
Koutsilieri, E, Scheller, C, ter, Meulen V, and Riederer, P
NEUROTOXICOLOGY 2004. 25(1-2): 267-270
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187910600029
28. 42800 HIV-LS-289; WOS-HIV-2/1/2004
Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages
Lu, R, Nakajima, N, Hofmann, W, Benkirane, M, Teh-Jeang, K, Sodroski, J, and Engelman, A
J VIROL 2004. 78(2): 658-668
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187957700012
29. 42801 HIV-LS-289; WOS-HIV-2/1/2004
The chemokine receptor CXCR4 and not the N-methyl-D-aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells
Bachis, A and Mocchetti, I
J NEUROSCI RES 2004. 75(1): 75-82
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187942100008
30. 42802 HIV-LS-289; WOS-HIV-2/1/2004
Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning
Zhang, MY, Shu, YU, Rudolph, D, Prabakaran, P, Labrijn, AF, Zwick, MB, Lal, RB, and Dimitrov, DS
J MOL BIOL 2004. 335(1): 209-219
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187879600016
31. 42803 HIV-LS-289; WOS-HIV-2/1/2004
High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B
Quinto, I, Puca, A, Greenhouse, J, Silvera, P, Yalley-Ogunro, J, Lewis, MG, Palmieri, C, Trimboli, F, Byrum, R, Adelsberger, J, Venzon, D, Chen, XN, and Scala, G
J BIOL CHEM 2004. 279(3): 1720-1728
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188005700021
32. 42804 HIV-LS-289; WOS-HIV-2/1/2004
Pyridoxal 5 '-phosphateas a novel weapon against autoimmunity and transplant rejection
Namazi, MR
FASEB J 2003. 17(15): 2184-2186
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188067500038
33. 42805 HIV-LS-289; WOS-HIV-2/1/2004
Fullerene derivatives: an attractive tool for biological applications
Bosi, S, da Ros, T, Spalluto, G, and Prato, M
EUR J MED CHEM 2003. 38(11-12): 913-923
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188000400001
34. 42806 HIV-LS-289; WOS-HIV-2/1/2004
Mechanisms of internalization and recycling of the chemokine receptor, CCR5
Mueller, A and Strange, PG
EUR J BIOCHEM 2004. 271(2): 243-252
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187958900002
35. 42807 HIV-LS-289; WOS-HIV-2/1/2004
Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells
Legrand, D, Vigie, K, Said, EA, Elass, E, Masson, M, Slomianny, MC, Carpentier, M, Briand, JP, Mazurier, J, and Hovanessian, AG
EUR J BIOCHEM 2004. 271(2): 303-317
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187958900008
36. 42808 HIV-LS-289; WOS-HIV-2/1/2004
Evolving therapeutic paradigms for HIV and HCV
Molla, A and Kohlbrenner, W
CURR OPIN BIOTECH 2003. 14(6): 634-640
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187924100012
37. 42809 HIV-LS-289; WOS-HIV-2/1/2004
Resistance towards exonucleases of dinucleotides with stereochemically altered internucleotide phosphate bonds
Nair, V and Pal, S
BIOORG MED CHEM LETT 2004. 14(1): 289-291
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187862000057
38. 42810 HIV-LS-289; WOS-HIV-2/1/2004
Purification of glysojanin, an antifungal protein, from the black soybean Glycine soja
Ngai, PHK and Ng, TB
BIOCHEM CELL BIOL 2003. 81(6): 387-394
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187992500005
39. 42811 HIV-LS-289; WOS-HIV-2/8/2004
The tat antagonist neomycin B hexa-arginine conjugate inhibits gp120-induced death of human neuroblastoma cells (1)
Lapidot, A, Catani, MV, Corasaniti, MT, Ranalli, M, Amantea, D, Litovchick, A, and Melino, G
J NEUROCHEM 2003. 87: 55
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187240200183
40. 42812 HIV-LS-289; WOS-HIV-2/8/2004
Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1
Kuritzkes, DR, Jacobson, J, Powderly, WG, Godofsky, E, DeJesus, E, Haas, F, Reimann, KA, Larson, JL, Yarbough, PO, Curt, V, and Shanahan, WR
J INFECT DIS 2004. 189(2): 286-291
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188097900016
41. 42813 HIV-LS-289; WOS-HIV-2/8/2004
A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics
Sadaie, AR, Mayner, R, and Doniger, J
ANTIVIR RES 2004. 61(1): 1-18
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188114900001
42. 42814 HIV-LS-289; WOS-HIV-2/8/2004
Interaction of sulfonated anionic porphyrins with HIV glycoprotein gp120: photodamages revealed by inhibition of antibody binding to V3 and C5 domains
Dairou, J, Vever-Bizet, C, and Brault, D
ANTIVIR RES 2004. 61(1): 37-47
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188114900004